Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

de

,

Éditeur :

Springer

Paru le : 2015-12-24

This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical manageme...
Voir tout
Ce livre est accessible aux handicaps Voir les informations d'accessibilité
Ebook téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Compatible lecture en ligne (streaming)
94,94
Ajouter à ma liste d'envies
Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

À propos


Éditeur

Collection
n.c

Parution
2015-12-24

Pages
231 pages

EAN papier
9783319249315

Auteur(s) du livre


Aamir Ahmad, PhD, is a Scientist at the Wayne State University School of Medicine Department of Pathology and the Karmanos Cancer Institute, with over 100 published scientific articles in peer-reviewed journals and many book chapters. He has been a member of leading cancer organizations such as American Association for Cancer Research (AACR, Philadelphia, USA) and International Union against Cancer (UICC, Geneva, Switzerland). In addition to serving as a reviewer for a number of peer-reviewed scientific journals, he is currently a Section Editor for the journal PLoS ONE responsible for policy drafts for the journal and identification and management of special issues. In addition to the current volume, Dr. Ahmad has worked with Springer to edit two more volumes, Breast Cancer Metastasis and Drug Resistance and Lung Cancer and Personalized Medicine: Current Knowledge and Therapies.Shirish M. Gadgeel is a Professor in the Department of Oncology at Karmanos Cancer Institute/Wayne State University in Detroit. He is also the co-leader of the Molecular Therapeutics Program of Karmanos Cancer Institute and the Leader of the Multidisciplinary Thoracic Oncology team. He is a member of several professional societies, including the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He currently serves on the Editorial Board of the journals Cancer and Clinical Lung Cancer. Dr. Gadgeel has been and is a Principal Investigator of several trials focused on the treatment of Lung Cancer. He has over 80 peer reviewed publications.  

Caractéristiques détaillées - droits

EAN PDF
9783319249322
Prix
94,94 €
Nombre pages copiables
2
Nombre pages imprimables
23
Taille du fichier
5202 Ko
EAN EPUB
9783319249322
Prix
94,94 €
Nombre pages copiables
2
Nombre pages imprimables
23
Taille du fichier
1423 Ko

Suggestions personnalisées